Skip to main content
Top
Published in: Pediatric Nephrology 4/2011

01-04-2011 | Original Article

Renal function in pediatric cystic fibrosis patients in the first decade of life

Authors: Chanel Prestidge, Mark A. Chilvers, A. George F. Davidson, Eva Cho, Vanessa McMahon, Colin T. White

Published in: Pediatric Nephrology | Issue 4/2011

Login to get access

Abstract

With increasing life expectancy and the need for lung transplantation in the cystic fibrosis (CF) population, there are increasing reports of chronic kidney disease (CKD). However, values for baseline or longitudinal glomerular filtration rate (GFR) as measured by exogenous clearance markers are lacking in this population. Retrospective cross-sectional study in 2 to 18-year-olds cared for at a single CF center who had a GFR measured by plasma disappearance of Technetium-99 m diethylenetriaminepentaacetic acid (mGFR). The primary outcome was evidence of renal dysfunction as defined by CKD stage II or below (mGFR < 90 ml/min/1.73 m2, persistent abnormalities in urinary sediment, abnormal renal imaging). Of 63 patients evaluated, four had apparent renal dysfunction, one demonstrated decreased mGFR, and three others had persistent microscopic hematuria. The mean mGFR was substantially higher (140 ± 24 ml/min/1.73 m2) than expected or previously reported for healthy children. We did not demonstrate the presence of significant renal impairment after limited aminoglycoside exposure in the first decade following diagnosis with CF. However, we did document the presence of glomerular hyperfiltration in a significant proportion of our CF patients.
Literature
1.
go back to reference Canadian Cystic Fibrosis Foundation (2007) Canadian Cystic Fibrosis patient data registry 2007 annual report Canadian Cystic Fibrosis Foundation (2007) Canadian Cystic Fibrosis patient data registry 2007 annual report
2.
go back to reference Crawford I, Maloney PC, Zeitlin PL, Guggino WB, Hyde SC, Turley H, Gatter KC, Harris A, Higgins CF (1991) Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci USA 88:9262–9266CrossRefPubMed Crawford I, Maloney PC, Zeitlin PL, Guggino WB, Hyde SC, Turley H, Gatter KC, Harris A, Higgins CF (1991) Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci USA 88:9262–9266CrossRefPubMed
3.
go back to reference Gibney EM, Goldfarb DS (2003) The association of nephrolithiasis with cystic fibrosis. Am J Kidney Dis 42:1–11CrossRefPubMed Gibney EM, Goldfarb DS (2003) The association of nephrolithiasis with cystic fibrosis. Am J Kidney Dis 42:1–11CrossRefPubMed
4.
go back to reference Augusto JF, Sayegh J, Malinge MC, Illouz F, Subra JF, Ducluzeau PH (2008) Severe episodes of extra cellular dehydration: an atypical adult presentation of cystic fibrosis. Clin Nephrol 69:302–305PubMed Augusto JF, Sayegh J, Malinge MC, Illouz F, Subra JF, Ducluzeau PH (2008) Severe episodes of extra cellular dehydration: an atypical adult presentation of cystic fibrosis. Clin Nephrol 69:302–305PubMed
5.
go back to reference Ballestero Y, Hernandez MI, Rojo P, Manzanares J, Nebreda V, Carbajosa H, Infante E, Baro M (2006) Hyponatremic dehydration as a presentation of cystic fibrosis. Pediatr Emerg Care 22:725–727CrossRefPubMed Ballestero Y, Hernandez MI, Rojo P, Manzanares J, Nebreda V, Carbajosa H, Infante E, Baro M (2006) Hyponatremic dehydration as a presentation of cystic fibrosis. Pediatr Emerg Care 22:725–727CrossRefPubMed
6.
go back to reference Glass S, Plant ND, Spencer DA (2005) The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis. J Cyst Fibros 4:221–225CrossRefPubMed Glass S, Plant ND, Spencer DA (2005) The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis. J Cyst Fibros 4:221–225CrossRefPubMed
7.
go back to reference Al-Aloul M, Miller H, Stockton P, Ledson MJ, Walshaw MJ (2005) Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES). J Cyst Fibros 4:197–201CrossRefPubMed Al-Aloul M, Miller H, Stockton P, Ledson MJ, Walshaw MJ (2005) Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES). J Cyst Fibros 4:197–201CrossRefPubMed
8.
go back to reference Bertenshaw C, Watson AR, Lewis S, Smyth A (2007) Survey of acute renal failure in patients with cystic fibrosis in the UK. Thorax 62:541–545CrossRefPubMed Bertenshaw C, Watson AR, Lewis S, Smyth A (2007) Survey of acute renal failure in patients with cystic fibrosis in the UK. Thorax 62:541–545CrossRefPubMed
9.
go back to reference Hmiel SP, Beck AM, de la Morena MT, Sweet S (2005) Progressive chronic kidney disease after pediatric lung transplantation. Am J Transplant 5:1739–1747CrossRefPubMed Hmiel SP, Beck AM, de la Morena MT, Sweet S (2005) Progressive chronic kidney disease after pediatric lung transplantation. Am J Transplant 5:1739–1747CrossRefPubMed
10.
go back to reference Hornum M, Iversen M, Steffensen I, Hovind P, Carlsen J, Andersen LW, Steinbruchel DA, Feldt-Rasmussen B (2009) Rapid decline in 51Cr-EDTA measured renal function during the first weeks following lung transplantation. Am J Transplant 9:1420–1426CrossRefPubMed Hornum M, Iversen M, Steffensen I, Hovind P, Carlsen J, Andersen LW, Steinbruchel DA, Feldt-Rasmussen B (2009) Rapid decline in 51Cr-EDTA measured renal function during the first weeks following lung transplantation. Am J Transplant 9:1420–1426CrossRefPubMed
11.
go back to reference Lefaucheur C, Nochy D, Amrein C, Chevalier P, Guillemain R, Cherif M, Jacquot C, Glotz D, Hill GS (2008) Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. Am J Transplant 8:1901–1910CrossRefPubMed Lefaucheur C, Nochy D, Amrein C, Chevalier P, Guillemain R, Cherif M, Jacquot C, Glotz D, Hill GS (2008) Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. Am J Transplant 8:1901–1910CrossRefPubMed
12.
go back to reference Meachery G, De Soyza A, Nicholson A, Parry G, Hasan A, Tocewicz K, Pillay T, Clark S, Lordan JL, Schueler S, Fisher AJ, Dark JH, Gould FK, Corris PA (2008) Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 63:725–731CrossRefPubMed Meachery G, De Soyza A, Nicholson A, Parry G, Hasan A, Tocewicz K, Pillay T, Clark S, Lordan JL, Schueler S, Fisher AJ, Dark JH, Gould FK, Corris PA (2008) Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 63:725–731CrossRefPubMed
13.
14.
go back to reference Al-Aloul M, Jackson M, Bell G, Ledson M, Walshaw M (2007) Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients. J Cyst Fibros 6:41–47CrossRefPubMed Al-Aloul M, Jackson M, Bell G, Ledson M, Walshaw M (2007) Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients. J Cyst Fibros 6:41–47CrossRefPubMed
15.
go back to reference Al-Aloul M, Miller H, Alapati S, Stockton PA, Ledson MJ, Walshaw MJ (2005) Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol 39:15–20CrossRefPubMed Al-Aloul M, Miller H, Alapati S, Stockton PA, Ledson MJ, Walshaw MJ (2005) Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol 39:15–20CrossRefPubMed
16.
go back to reference Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS (2003) National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421CrossRefPubMed Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS (2003) National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421CrossRefPubMed
17.
go back to reference Jusko WJ, Mosovich LL, Gerbracht LM, Mattar ME, Yaffe SJ (1975) Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics 56:1038–1044PubMed Jusko WJ, Mosovich LL, Gerbracht LM, Mattar ME, Yaffe SJ (1975) Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics 56:1038–1044PubMed
18.
go back to reference Kassirer JP (1971) Clinical evaluation of kidney function–glomerular function. N Engl J Med 285:385–389CrossRefPubMed Kassirer JP (1971) Clinical evaluation of kidney function–glomerular function. N Engl J Med 285:385–389CrossRefPubMed
19.
go back to reference Windstetter D, Schaefer F, Scharer K, Reiter K, Eife R, Harms HK, Bertele-Harms R, Fiedler F, Tsui LC, Reitmeir P, Horster M, Hadorn HB (1997) Renal function and renotropic effects of secretin in cystic fibrosis. Eur J Med Res 2:431–436PubMed Windstetter D, Schaefer F, Scharer K, Reiter K, Eife R, Harms HK, Bertele-Harms R, Fiedler F, Tsui LC, Reitmeir P, Horster M, Hadorn HB (1997) Renal function and renotropic effects of secretin in cystic fibrosis. Eur J Med Res 2:431–436PubMed
20.
go back to reference Arvidsson A, Alvan G, Strandvik B (1983) Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects. Acta Paediatr Scand 72:293–294CrossRefPubMed Arvidsson A, Alvan G, Strandvik B (1983) Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects. Acta Paediatr Scand 72:293–294CrossRefPubMed
21.
go back to reference Assael BM, Marra G, Tirelli AS, Cavanna G, Claris Appiani A, Giunta A, Amoretti M, Milani S (1986) Renal function in cystic fibrosis. Int J Pediatr Nephrol 7:213–216PubMed Assael BM, Marra G, Tirelli AS, Cavanna G, Claris Appiani A, Giunta A, Amoretti M, Milani S (1986) Renal function in cystic fibrosis. Int J Pediatr Nephrol 7:213–216PubMed
22.
go back to reference Berg U, Kusoffsky E, Strandvik B (1982) Renal function in cystic fibrosis with special reference to the renal sodium handling. Acta Paediatr Scand 71:833–838CrossRefPubMed Berg U, Kusoffsky E, Strandvik B (1982) Renal function in cystic fibrosis with special reference to the renal sodium handling. Acta Paediatr Scand 71:833–838CrossRefPubMed
23.
go back to reference Beringer PM, Hidayat L, Heed A, Zheng L, Owens H, Benitez D, Rao AP (2009) GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis. J Cyst Fibros 8:19–25CrossRefPubMed Beringer PM, Hidayat L, Heed A, Zheng L, Owens H, Benitez D, Rao AP (2009) GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis. J Cyst Fibros 8:19–25CrossRefPubMed
24.
go back to reference Hedman A, Adan-Abdi Y, Alvan G, Strandvik B, Arvidsson A (1988) Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis. Clin Pharmacokinet 15:57–65CrossRefPubMed Hedman A, Adan-Abdi Y, Alvan G, Strandvik B, Arvidsson A (1988) Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis. Clin Pharmacokinet 15:57–65CrossRefPubMed
25.
go back to reference Hedman A, Alvan G, Strandvik B, Arvidsson A (1990) Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis. Clin Pharmacokinet 18:168–175CrossRefPubMed Hedman A, Alvan G, Strandvik B, Arvidsson A (1990) Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis. Clin Pharmacokinet 18:168–175CrossRefPubMed
26.
go back to reference Levy J, Smith AL, Koup JR, Williams-Warren J, Ramsey B (1984) Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study. J Pediatr 105:117–124CrossRefPubMed Levy J, Smith AL, Koup JR, Williams-Warren J, Ramsey B (1984) Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study. J Pediatr 105:117–124CrossRefPubMed
27.
go back to reference Robson AM, Tateishi S, Ingelfinger JR, Strominger DB, Klahr S (1971) Renal function in patients with cystic fibrosis. J Pediatr 79:42–50CrossRefPubMed Robson AM, Tateishi S, Ingelfinger JR, Strominger DB, Klahr S (1971) Renal function in patients with cystic fibrosis. J Pediatr 79:42–50CrossRefPubMed
28.
go back to reference Spino M, Chai RP, Isles AF, Balfe JW, Brown RG, Thiessen JJ, MacLeod SM (1985) Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis. J Pediatr 107:64–70CrossRefPubMed Spino M, Chai RP, Isles AF, Balfe JW, Brown RG, Thiessen JJ, MacLeod SM (1985) Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis. J Pediatr 107:64–70CrossRefPubMed
29.
go back to reference Stenvinkel P, Hjelte L, Alvan G, Hedman A, Hultman E, Strandvik B (1991) Decreased renal clearance of sodium in cystic fibrosis. Acta Paediatr Scand 80:194–198CrossRefPubMed Stenvinkel P, Hjelte L, Alvan G, Hedman A, Hultman E, Strandvik B (1991) Decreased renal clearance of sodium in cystic fibrosis. Acta Paediatr Scand 80:194–198CrossRefPubMed
30.
go back to reference Vogelstein B, Kowarski A, Lietman PS (1977) The pharmacokinetics of amikacin in children. J Pediatr 91:333–339CrossRefPubMed Vogelstein B, Kowarski A, Lietman PS (1977) The pharmacokinetics of amikacin in children. J Pediatr 91:333–339CrossRefPubMed
31.
go back to reference Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Pappas LM, Cheung AK (2003) Creatinine production, nutrition, and glomerular filtration rate estimation. J Am Soc Nephrol 14:1000–1005CrossRefPubMed Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Pappas LM, Cheung AK (2003) Creatinine production, nutrition, and glomerular filtration rate estimation. J Am Soc Nephrol 14:1000–1005CrossRefPubMed
32.
go back to reference National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266CrossRef National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266CrossRef
33.
go back to reference Piepsz A, Tondeur M, Ham H (2006) Revisiting normal (51)Cr-ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging 33:1477–1482CrossRefPubMed Piepsz A, Tondeur M, Ham H (2006) Revisiting normal (51)Cr-ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging 33:1477–1482CrossRefPubMed
34.
go back to reference Piepsz A, Tondeur M, Ham H (2008) Escaping the correction for body surface area when calculating glomerular filtration rate in children. Eur J Nucl Med Mol Imaging 35:1669–1672CrossRefPubMed Piepsz A, Tondeur M, Ham H (2008) Escaping the correction for body surface area when calculating glomerular filtration rate in children. Eur J Nucl Med Mol Imaging 35:1669–1672CrossRefPubMed
35.
go back to reference Soulsby N, Greville H, Coulthard K, Doecke C (2010) What is the best method for measuring renal function in adults and children with cystic fibrosis? J Cyst Fibros 9:124–129CrossRefPubMed Soulsby N, Greville H, Coulthard K, Doecke C (2010) What is the best method for measuring renal function in adults and children with cystic fibrosis? J Cyst Fibros 9:124–129CrossRefPubMed
36.
go back to reference Schnermann J, Briggs JP, Weber PC (1984) Tubuloglomerular feedback, prostaglandins, and angiotensin in the autoregulation of glomerular filtration rate. Kidney Int 25:53–64CrossRefPubMed Schnermann J, Briggs JP, Weber PC (1984) Tubuloglomerular feedback, prostaglandins, and angiotensin in the autoregulation of glomerular filtration rate. Kidney Int 25:53–64CrossRefPubMed
37.
go back to reference Strandvik B, Berg U, Kallner A, Kusoffsky E (1989) Effect on renal function of essential fatty acid supplementation in cystic fibrosis. J Pediatr 115:242–250CrossRefPubMed Strandvik B, Berg U, Kallner A, Kusoffsky E (1989) Effect on renal function of essential fatty acid supplementation in cystic fibrosis. J Pediatr 115:242–250CrossRefPubMed
38.
go back to reference Christophe AB, Warwick WJ, Holman RT (1994) Serum fatty acid profiles in cystic fibrosis patients and their parents. Lipids 29:569–575CrossRefPubMed Christophe AB, Warwick WJ, Holman RT (1994) Serum fatty acid profiles in cystic fibrosis patients and their parents. Lipids 29:569–575CrossRefPubMed
39.
go back to reference Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, Alvarez JG, O'Sullivan BP (2004) Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350:560–569CrossRefPubMed Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, Alvarez JG, O'Sullivan BP (2004) Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350:560–569CrossRefPubMed
40.
go back to reference Roulet M, Frascarolo P, Rappaz I, Pilet M (1997) Essential fatty acid deficiency in well-nourished young cystic fibrosis patients. Eur J Pediatr 156:952–956CrossRefPubMed Roulet M, Frascarolo P, Rappaz I, Pilet M (1997) Essential fatty acid deficiency in well-nourished young cystic fibrosis patients. Eur J Pediatr 156:952–956CrossRefPubMed
41.
go back to reference Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlstrom J (2001) Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 139:650–655CrossRefPubMed Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlstrom J (2001) Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 139:650–655CrossRefPubMed
42.
go back to reference Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG (2009) Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52:691–697CrossRefPubMed Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG (2009) Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52:691–697CrossRefPubMed
43.
go back to reference Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356–360CrossRefPubMed Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356–360CrossRefPubMed
44.
go back to reference Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R, Winnicki M, Dal Follo M, Biasion T, Garavelli G, Pessina AC (2006) Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int 70:578–584PubMed Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R, Winnicki M, Dal Follo M, Biasion T, Garavelli G, Pessina AC (2006) Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int 70:578–584PubMed
45.
go back to reference Dobson L, Stride A, Bingham C, Elworthy S, Sheldon CD, Hattersley AT (2005) Microalbuminuria as a screening tool in cystic fibrosis-related diabetes. Pediatr Pulmonol 39:103–107CrossRefPubMed Dobson L, Stride A, Bingham C, Elworthy S, Sheldon CD, Hattersley AT (2005) Microalbuminuria as a screening tool in cystic fibrosis-related diabetes. Pediatr Pulmonol 39:103–107CrossRefPubMed
46.
go back to reference Kalaitzidis RG, Bakris GL (2009) Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease? Curr Opin Nephrol Hypertens 18:386–391CrossRefPubMed Kalaitzidis RG, Bakris GL (2009) Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease? Curr Opin Nephrol Hypertens 18:386–391CrossRefPubMed
47.
go back to reference Filler G, Foster J, Acker A, Lepage N, Akbari A, Ehrich JH (2005) The Cockcroft-Gault formula should not be used in children. Kidney Int 67:2321–2324CrossRefPubMed Filler G, Foster J, Acker A, Lepage N, Akbari A, Ehrich JH (2005) The Cockcroft-Gault formula should not be used in children. Kidney Int 67:2321–2324CrossRefPubMed
48.
go back to reference Chantler C, Garnett ES, Parsons V, Veall N (1969) Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 37:169–180PubMed Chantler C, Garnett ES, Parsons V, Veall N (1969) Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 37:169–180PubMed
49.
go back to reference Griffiths PD, Drolc Z, Green A, Taylor CM, White RH (1988) Comparison of 51Cr-EDTA and 99mTc-DTPA slope clearances in children with vesicoureteric reflux. Child Nephrol Urol 9:283–285PubMed Griffiths PD, Drolc Z, Green A, Taylor CM, White RH (1988) Comparison of 51Cr-EDTA and 99mTc-DTPA slope clearances in children with vesicoureteric reflux. Child Nephrol Urol 9:283–285PubMed
Metadata
Title
Renal function in pediatric cystic fibrosis patients in the first decade of life
Authors
Chanel Prestidge
Mark A. Chilvers
A. George F. Davidson
Eva Cho
Vanessa McMahon
Colin T. White
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 4/2011
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-010-1737-1

Other articles of this Issue 4/2011

Pediatric Nephrology 4/2011 Go to the issue